Jun
03
2020
Antibodies that Target Toxic Amyloid-β Oligomers
One possible expansion of present immunotherapies for Alzheimer’s disease is to more specifically track and target oligomeric forms of amyloid-β. Efforts to reduce amyloid-β in the brain have, after many...